Literature DB >> 8615872

Structure-dependent induction of CYP2B by polychlorinated biphenyl congeners in female Sprague-Dawley rats.

K Connor1, S Safe, C R Jefcoate, M Larsen.   

Abstract

The dose-response induction of hepatic microsomal pentoxyresorufin O-dealkylase (PROD) activity by phenobarbital (PB) and several polychlorinated biphenyl (PCB) mixtures and congeners was determined in the immature female Sprague-Dawley rat. At a dose of 75 mg/kg/day of PB for 3 days, the microsomal PROD activity was 2154 pmol/min/mg protein. Aroclors 1260, 1254, 1242, and 1016 did not induce maximal PROD activity at doses up to 500 mg/kg, and only Aroclor 1016 induced > a half-maximal response at the 500 mg/kg dose. The relative potencies of eighteen different PCB congeners were also determined, and the structures of these compounds differed with respect to the degree of chlorination (tri- to octochloro) and substitution patterns. The relative potencies of these compounds were estimated by comparing their induced activities at the high dose (150 or 100 mg/kg) with that of PB. The most potent inducers were 2,3,3',4',5,6-hexaCB and 2,2',3,4',5,5',6-heptaCB; at a dose of 150 mg/kg, the PROD activity induced by 2,2'3,4',5,5',6-heptaCB was comparable to that observed for PB. 2,3,3',4',5,6-HexaCB was the most potent inducer, and hepatic PROD activity in rats treated with 150 mg/kg was 4202 pmol/min/mg; this value was higher than that observed for PB at a dose of 75 mg/kg. A second group of congeners including 2,2',3,4,4',5,5'-heptaCB, 2,2',4,4',5,5'-hexaCB, 2,2',3,3',4,4',5,5'-octaCB 2,2',4,4'-tetraCB, 2,2',4,5,5'-pentaCB, 2,2',3,4,4',5',6-heptaCB, 2,2',4,4',5-pentaCB and 2,2',3,3',4',5,5',6-octaCB induced PROD activity > or = 1090 pmol/min/mg at the 150 mg/kg dose, and this value was > 50% of the maximal response observed for PB. The remaining compounds, namely 2,4,4'-triCB, 2,2',3,4'-tetraCB, 2,2',5,5'-tetraCB, 2,3',4,4',5-pentaCB, 2,3,3',4,4'-pentaCB, 2,2',4,4',5,6'-hexaCB, 2,3,3',4,4',5,5'-heptaCB and 2,2',3,3',4,4,5-heptaCB were all relatively weak inducers of hepatic microsomal PROD activity ( < 450 pmol/min/mg). In parallel experiments, western blot analysis of immunoreactive CYP2B1 and CYP2B2 protein showed that PB, the PCB mixtures, and congeners induced both proteins. Previous studies have identified a cis-acting DNA element that plays a role in regulating CYP2B1/B2 gene expression and binds nuclear trans-acting factor(s) induced by PB. The results of gel electrophoretic mobility shift assays with nuclear extracts showed that both PB and 2,2',3,4',5,5',6-heptaCB induce formation of a common retarded band using a 32P-labeled oligonucleotide corresponding the the cis-acting DNA promoter sequence. Both PB and PCBs appear to induce CYP2B1/B2 via a common mechanism. Although the results of this study do not define structure-induction (CYP2B1/B2) relationships for PCBs, two compounds, namely 2,3,3',4',5,6-hexaCB and 2,2',3,4',5,5',6-heptaCB, were identified as highly potent inducers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8615872     DOI: 10.1016/0006-2952(95)02087-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

2.  Differential effects of polychlorinated biphenyl congeners on serum thyroid hormone levels in rats.

Authors:  Lori Martin; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2010-06-23       Impact factor: 4.849

3.  Cytochrome P450 CYP2 genes in the common cormorant: Evolutionary relationships with 130 diapsid CYP2 clan sequences and chemical effects on their expression.

Authors:  Akira Kubota; John J Stegeman; Jared V Goldstone; David R Nelson; Eun-Young Kim; Shinsuke Tanabe; Hisato Iwata
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2010-12-03       Impact factor: 3.228

4.  Proposed PCB congener groupings for epidemiological studies.

Authors:  M S Wolff; D Camann; M Gammon; S D Stellman
Journal:  Environ Health Perspect       Date:  1997-01       Impact factor: 9.031

5.  PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands.

Authors:  Anna K Kopec; Lyle D Burgoon; Daher Ibrahim-Aibo; Bryan D Mets; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-18       Impact factor: 4.219

6.  Subchronic inhalation exposure study of an airborne polychlorinated biphenyl mixture resembling the Chicago ambient air congener profile.

Authors:  Xin Hu; Andrea Adamcakova-Dodd; Hans-Joachim Lehmler; Dingfei Hu; Keri Hornbuckle; Peter S Thorne
Journal:  Environ Sci Technol       Date:  2012-08-24       Impact factor: 9.028

7.  The environmental estrogen, nonylphenol, activates the constitutive androstane receptor.

Authors:  Juan P Hernandez; Wendong Huang; Laura M Chapman; Steven Chua; David D Moore; William S Baldwin
Journal:  Toxicol Sci       Date:  2007-05-05       Impact factor: 4.849

8.  Bayesian Analysis of a Lipid-Based Physiologically Based Toxicokinetic Model for a Mixture of PCBs in Rats.

Authors:  Alan F Sasso; Panos G Georgopoulos; Sastry S Isukapalli; Kannan Krishnan
Journal:  J Toxicol       Date:  2012-01-19

9.  Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression.

Authors:  Chad M Vezina; Nigel J Walker; James R Olson
Journal:  Environ Health Perspect       Date:  2004-11       Impact factor: 9.031

10.  Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism.

Authors:  Kevin M Crofton; Elena S Craft; Joan M Hedge; Chris Gennings; Jane E Simmons; Richard A Carchman; W Hans Carter; Michael J DeVito
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.